s Business, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 38Figure 19: Speciality Beds Sales Business, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 39Figure 20: Speciality Beds Sales Business, Brazil, Volume (Units), Historic, 2004-2011 40Figure 21: Speciality Beds Sales Business, Brazil, Volume (Units), Forecast, 2011-2018 41Figure 22: Speciality Beds Rental Business, Brazil, Company Share (%), 2011 43Figure 23: Pressure Relief Devices, Brazil, Company Share (%), 2011 44Figure 24: Pressure Relief Devices, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 46Figure 25: Pressure Relief Devices, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011 47Figure 26: Pressure Relief Devices, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 49Figure 27: Mattress Overlays, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 51Figure 28: Mattress Overlays, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 52Figure 29: Mattress Overlays, Russian Federation, Volume (Units), Historic, 2004-2011 53Figure 30: Mattress Overlays, Russian Federation, Volume (Units), Forecast, 2011-2018 54Figure 31: Speciality Beds Rental Business, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 56Figure 32: Speciality Beds Rental Business, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 57Figure 33: Mattresses, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 58Figure 34: Mattresses, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 59Figure 35: Mattresses, Russian Federation, Volume (Units), Historic, 2004-2011 60Figure 36: Mattresses, Russian Federation, Volume (Units), Forecast, 2011-2018 61Figure 37: Speciality Beds Sales Business, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 63Figure 38: Speciality Beds Sales Business, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-
'/>"/>SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Related medicine technology :1.
Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services2.
Failure to Take Medicine Linked to Unnecessary Hospital Visits, Especially for Medicare Patients Taking High Blood Pressure or High Cholesterol Medications3.
Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update4.
Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting5.
Negative Pressure Wound Therapy (NPWT) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 20186.
Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities7.
Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies8.
MinuteClinic Joins with American Heart Association to Help Americans Reduce High Blood Pressure9.
Long-Term Use of Blood Pressure Medications that Promote Sun Sensitivity May Increase Risk of Lip Cancer in Non-Hispanic Whites10.
Social Norms, Life Changes and Increasing Pressures Contribute to Substance Abuse Among Adult Women11.
Pressure BioSciences, Inc. to Discuss Second Quarter 2012 Financial Results and Provide Business Update